Hepion Pharmaceuticals, Inc. (HEPA) › Shareholders' EquityHepion Pharmaceuticals, Inc. (HEPA) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2013: -$140.5K2014: -$2.93M2015: $3.44M2016: $1.32M2017: $3.70M2018: $1.72M2019: $15.62M2020: $40.52M2021: $93.00M2022: $49.86M2023: $7.28M2024: -$1.86M2025: $2.67M$2.67M2013Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$2.67M+243.2%2024-$1.86M-125.6%2023$7.28M-85.4%2022$49.86M-46.4%2021$93.00M+129.5%2020$40.52M+159.5%2019$15.62M+805.4%2018$1.72M-53.4%2017$3.70M+181.1%2016$1.32M-61.7%2015$3.44M+217.2%2014-$2.93M-1987.7%2013-$140.5K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share